Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis

Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis The approved product is a generic version of Biogen Inc’s Tecfidera delayed-release capsules.

from Moneycontrol Business News https://ift.tt/3nAbomm
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...